Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Bionovo's Estrogen Receptor Beta Selective Drugs Have Unique Gene Expression And Cell Type Specificity
Bionovo, Inc. (Nasdaq: BNVI) announced that a study of the gene regulation in multiple cell lines by several of their estrogen receptor beta (ERb) candidates will be published in Public Library of Science One.
generic viagra online
U.S. Naval Medical Research Center Proposed 'RESUS' Clinical Trial In Trauma Patients Remains On FDA Hold
Biopure Corporation (Nasdaq: BPUR) announced that the Food and Drug Administration has advised the U.S. Naval Medical Research Center (NMRC) by letter that it may not initiate a clinical trial of Biopure"s oxygen therapeutic Hemopure(R) [hemoglobin glutamer -- 250 (bovine)] under a proposed protocol submitted to the FDA in March 2009. As previously announced, the study, "Restore Effective Survival in Shock" (RESUS) was first proposed and submitted to the FDA in 2005. The proposed trial was placed on clinical hold at that time. It has been resubmitted repeatedly in response to FDA comments and to address comments made by the FDA Blood Products Advisory Committee at an open meeting held in December 2006. Each subsequent submission, including the most recent, was placed on clinical hold.
News of the day
Nursing Shortage Eases With Recession's Help
"The nation"s deep recession is helping to alleviate the decade-long nursing shortage, as workers who had left the field in better times are returning in droves," the Wall Street Journal reports. The paper quotes a study, one of six papers on the nursing workforce published today in the journal Health Affairs, that found "nearly a quarter-million nurses entered the work force in 2007-08, an 18% surge that was the largest two-year increase in at least three decades." Many of them had left nursing, but "re-entered the work force to compensate for a spouse"s lost income or health benefits, the study said." The increase is "particularly remarkable at a time when the U.S. economy has shed more than six million jobs, helping to solidify the profession"s "recession-proof" image." The study found that the surge in new nurses is due to "efforts to expand nursing schools, attract more young people into the field and improve working conditions," along with an increase in the number of foreign-born nurses.
Health Insurance

Grants To Fund Research Critical To US And Honors From White House

Benjamin tenOever, Ph.D., Assistant Professor in the Department of Microbiology at Mount Sinai School of Medicine, has been selected by the United States government for a Presidential Early Career Award for Scientists and Engineers (PECASE). The White House announced the 100 honorees on July 9 and will host them at a reception with President Barack Obama. The highest honor bestowed by the country on young professionals in the early stages of their research careers, the award comes with $500,000 in research funding over a five year span. The Department of Defense, which nominated Dr. tenOever, will match this amount, giving him $1 million for research over five years. Dr. tenOever"s lab focuses on developing novel vaccine strategies to combat influenza virus and other emerging pathogens. "My receipt of this Presidential Award reflects the priority Mount Sinai School of Medicine places on discoveries that have immediate impact on human health," said Dr. tenOever. "This is truly one of the greatest honors bestowed upon me thus far in my career, and my work is just one of scores of translational research projects the Medical School has made possible through its commitment to breakthrough science." In a White House press release, President Obama called the honorees "the best in our country" and said he is confident they will "help us use science and technology to lift up our nation and our world." Nominees are chosen annually by nine Federal departments and agencies. Award selections are based on two criteria: pursuit of innovative research at the frontiers of science, and technology and a commitment to community service. Dr. tenOever and his team study cellular response to RNA virus infections - the genetic interactions that occur within cells attacked by virus - as well as processes that render cells resistant to infection, in the hope of reducing the global burden from such pathogens. "The National Science and Technology Council"s recognition of Dr. tenOever"s work and contributions will help us further the study of viral infection," said Dennis S. Charney, M.D., the Anne and Joel Ehrenkranz Dean of Mount Sinai School of Medicine and Executive Vice President for Academic Affairs at The Mount Sinai Medical Center. "Mount Sinai"s ability to secure research funding, such as the Presidential Award, is critical to our mission of discovering tomorrow"s cures today." This is not the first time Dr. tenOever"s research has earned accolades. A year ago, he was selected as a Pew Scholar in the Biomedical Sciences, an honor that acknowledges and supports promising young investigators in advancing human health. Dr. tenOever was one of 20 scientists chosen by The Pew Charitable Trusts and the University of California at San Francisco, which provide this distinction. Dr. tenOever received a doctorate in virology from McGill University in 2004. He engaged in postdoctoral research at Harvard University from 2004 to 2007. He then joined the staff at Mount Sinai School of Medicine in the Department of Microbiology. Kevin Orozovich The Mount Sinai Hospital / Mount Sinai School of Medicine


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009